Wills v. Microgenics Corporation

District Court, E.D. New York·Decided August 10, 2021·No. 1:20-cv-04432·Unknown

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK ---------------------------------------------------------- X : RUBEN WILLS, : : MEMORANDUM DECISION Plaintiff, : AND ORDER : - against - : 20-cv-4432 (BMC) : MICROGENICS CORPORATION; : THERMO FISHER SCIENTIFIC, INC.; : ANTHONY J. ANNUCCI; DELTA : BAROMETRE; SHAUNTE MITCHELL; : MALIKAH MCCROREY; SHEILA : WOODBERRY; and CAPTAIN DOE;* : : Defendants. : : ---------------------------------------------------------- X

COGAN, District Judge.

Plaintiff Ruben Wills, a former inmate, has sued several prison officials under 42 U.S.C. § 1983. These officials – Anthony Annucci, Delta Barometre, Shaunte Mitchell, Malikah McCrorey, and Sheila Woodberry (“defendants”) – allegedly violated the Due Process Clause of the Fourteenth Amendment by punishing plaintiff for having medication that he was permitted to take. When defendants moved to dismiss the Second Amended Complaint, plaintiff abandoned his claims against Barometre, Mitchell, and McCrorey, opting to pursue only the claims against Annucci and Woodberry. Because plaintiff has not adequately alleged that Annucci was personally involved in the constitutional violation, the claims against him are dismissed. But the motion is denied as to

* Although the Second Amended Complaint asserted a claim against “Corey Woodberry,” the parties have clarified that her name is Sheila Woodberry. The Clerk is directed to correct the docket sheet accordingly. Woodberry, for plaintiff has stated a claim under § 1983 and Woodberry is not entitled to qualified immunity. SUMMARY OF THE COMPLAINT Plaintiff is a former member of the New York City Council. He was convicted on corruption charges but later had his conviction reversed on direct appeal. See People v. Wills,

186 A.D.3d 1416, 130 N.Y.S.3d 93 (2d Dep’t 2020). While still incarcerated, he was granted temporary work release and moved to Lincoln Correctional Facility in New York City, where he could work in the community. Plaintiff alleges that, after approximately eight months in the temporary work release program, he “was issued a Notification of Earned Eligibility Determination, which qualified him to be released on parole.” At Lincoln, plaintiff specifically told the medical staff that he needed over-the-counter medication for his allergies. They responded that he could indeed take this medication. The Lincoln Offenders Orientation Manual also specifically stated that he could take over-the- counter medications. Plaintiff chose Benadryl. Before his release, however, plaintiff was given a random drug test. The test used an

Indiko Plus urinalysis analyzer manufactured by Microgenics Corporation. It returned positive for “Buprenorphine II.” According to plaintiff, “buprenorphine is most commonly used as a component of Suboxone, a drug used to combat opiate addiction.” That drug helps individuals “control the symptoms of their addiction,” and it “is almost never abused recreationally.” Plaintiff also notes that he had no history of any drug use. He thus alleges that the test was a false positive, a result of Microgenics’s defective urinalysis analyzer. Despite plaintiff’s demands for a second test, defendants held a disciplinary hearing on March 30, 2019. Plaintiff did not prevail. He “was given 30 days keeplock, suspended for 60 days, and a referral to the Temporary Release Committee.” He immediately appealed. Two days after the hearing, plaintiff told an officer that Benadryl might have caused the false-positive result. The next day, April 2, plaintiff was removed from eligibility for presumptive parole. Officers then searched plaintiff’s locker and uncovered Benadryl pills. Plaintiff alleges that he “was issued a violation,” even though Benadryl was a permitted over-

the-counter medication. On April 8, plaintiff had another disciplinary hearing. Woodberry determined that plaintiff had violated Lincoln’s rules by possessing Benadryl, even though the rules “made it clear” that plaintiff “was in fact permitted to take this medication.” On April 9, the Temporary Release Committee decided to remove plaintiff from the program, and plaintiff was transferred to another facility. Plaintiff made several more appeals, but to no avail. At the last step, Annucci, as the Acting Director of the New York State Department of Corrections and Community Supervision, “personally reviewed the case and confirmed the disciplinary decision.” Soon after, plaintiff’s “Earned Eligibility Determination was revoked.”

Plaintiff insists that, because of defendants’ actions, he remained incarcerated for “months later than he should have been.” He “would have been granted parole on April 2,” he explains, but he was not released until August 12. Plaintiff does not specify why he was released, and the release date is over a year before the Appellate Division reversed plaintiff’s conviction. After his release, plaintiff brought the § 1983 claims against defendants, alleging violations of his right to procedural due process. Plaintiff also brought state-law negligence claims against Microgenics and its parent corporation. In a separate decision, I denied a motion to dismiss the negligence claims. See Wills v. Microgenics Corp., No. 20-cv-4432, 2021 WL 1838275 (E.D.N.Y. May 7, 2021). Defendants then brought this motion. They maintain that plaintiff has not stated a claim under § 1983 and that they are entitled to qualified immunity. DISCUSSION I. Legal Framework “Federal courts ‘examine procedural due process questions in two steps: the first asks whether there exists a liberty or property interest which has been interfered with by the State; the

second examines whether the procedures attendant upon that deprivation were constitutionally sufficient.’” Francis v. Fiacco, 942 F.3d 126, 141 (2d Cir. 2019) (quoting Ky. Dep’t of Corr. v. Thompson, 490 U.S. 454, 460 (1989)). “A liberty interest may arise from the Constitution itself, by reason of guarantees implicit in the word ‘liberty,’ or it may arise from an expectation or interest created by state laws or policies.” Id. (quoting Wilkinson v. Austin, 545 U.S. 209, 221 (2005)). If a plaintiff has a protected liberty interest, “the next question is ‘what process is due.’” Id. at 142 (quoting Morrissey v. Brewer, 408 U.S. 471, 481 (1972)). Due process is a flexible concept, and “the quantum and quality of the process due in a particular situation depend upon the need to serve the purpose of minimizing the risk of error.” Greenholtz v. Inmates of Neb.

Penal & Corr. Complex, 442 U.S. 1, 13 (1979). Here, the complaint raises three possible deprivations of a protected liberty interest: (1) the removal of plaintiff’s eligibility for presumptive parole; (2) the revocation of his “Earned Eligibility Determination”; and (3) his removal from the temporary work release program. According to plaintiff, these deprivations occurred without due process of law because he did not receive adequate notice that Lincoln’s rules prohibited his possession of Benadryl. I will address each deprivation in turn.1

1 Plaintiff can count himself fortunate that “the essence of a cause of action is found in the facts alleged and proven by the plaintiff, not the particular legal theories articulated.” Oneida Indian Nation of N.Y. v. Cty. of Oneida, 617 II. Removal from Eligibility for Presumptive Parole Plaintiff has not adequately alleged that this first deprivation occurred without due process.

Free access — add to your briefcase to read the full text and ask questions with AI

Wills v. Microgenics Corporation, (E.D.N.Y. 2021).

Wills v. Microgenics Corporation (Wills v. Microgenics Corporation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Morrissey v. Brewer
408 U.S. 471 (Supreme Court, 1972)
Wolff v. McDonnell
418 U.S. 539 (Supreme Court, 1974)
Kentucky Department of Corrections v. Thompson
490 U.S. 454 (Supreme Court, 1989)
Heck v. Humphrey
512 U.S. 477 (Supreme Court, 1994)
Hope v. Pelzer
536 U.S. 730 (Supreme Court, 2002)
Muhammad v. Close
540 U.S. 749 (Supreme Court, 2004)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Pearson v. Callahan
555 U.S. 223 (Supreme Court, 2009)
Tracy v. Salamack
572 F.2d 393 (Second Circuit, 1978)
Larry Coffman v. Myrna Trickey
884 F.2d 1057 (Eighth Circuit, 1989)
Glenn Wallace v. John Nash, Warden
311 F.3d 140 (Second Circuit, 2002)
Anderson v. Recore
317 F.3d 194 (Second Circuit, 2003)
Anderson v. Recore
446 F.3d 324 (Second Circuit, 2006)
Wilkinson v. Austin
545 U.S. 209 (Supreme Court, 2005)
Higazy v. Templeton
505 F.3d 161 (Second Circuit, 2007)
Clarkson v. Coughlin
898 F. Supp. 1019 (S.D. New York, 1995)
Abdur-Raheem v. Selsky
598 F. Supp. 2d 367 (W.D. New York, 2009)
Richardson v. Coughlin
763 F. Supp. 1228 (S.D. New York, 1991)